Number of Courses of Induction Therapy Independently Predicts Outcome after Allogeneic Transplantation for Acute Myeloid Leukemia in First Morphological Remission-Reference-Cited by-同舟云学术

Number of Courses of Induction Therapy Independently Predicts Outcome after Allogeneic Transplantation for Acute Myeloid Leukemia in First Morphological Remission

Published:2015-02 Issue:2 Volume:21 Page:373-378
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Walter Roland B.,Sandmaier Brenda M.,Storer Barry E.,Godwin Colin D.,Buckley Sarah A.,Pagel John M.,Sorror Mohamed L.,Deeg H. Joachim,Storb Rainer,Appelbaum Frederick R.

Funder

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference32 articles.

1. Concise review: the role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia;Hamilton;Stem Cells,2012

2. The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach;Cornelissen;Nat Rev Clin Oncol,2012

3. Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia;Dominietto;Curr Opin Hematol,2011

4. Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia;Buccisano;Blood,2012

5. Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia;Buckley;Bone Marrow Transplant,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study;Cancer;2024-04-06

3. Re-induction therapy in patients with acute myeloid leukemia not in complete remission after the first course of treatment;Annals of Hematology;2023-01-12

4. Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia;Cancers;2023-01-05

5. Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remission;Bone Marrow Transplantation;2022-12-28